האיחוד האירופי - איסלנדית - EMA (European Medicines Agency)

deciphera pharmaceuticals (netherlands) b.v. - ripretinib - gastrointestinal stromal tumors - Æxlishemjandi lyf - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.

האיחוד האירופי - איסלנדית - EMA (European Medicines Agency)

siga technologies netherlands b.v. - tecovirimat - poxviridae infections; cowpox; monkeypox; vaccinia; smallpox - veirueyðandi lyf til almennrar notkunar - tecovirimat siga is indicated for the treatment of the following viral infections in adults and children with body weight at least 13 kg:- smallpox- monkeypox- cowpoxtecovirimat siga is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13 kg (see sections 4. 4 og 5. tecovirimat siga should be used in accordance with official recommendations.

האיחוד האירופי - איסלנדית - EMA (European Medicines Agency)

otsuka pharmaceutical netherlands b.v. - voclosporin - lupus nephritis - Ónæmisbælandi lyf - lupkynis is indicated in combination with mycophenolate mofetil for the treatment of adult patients with active class iii, iv or v (including mixed class iii/v and iv/v) lupus nephritis (ln).

האיחוד האירופי - איסלנדית - EMA (European Medicines Agency)

agios netherlands b.v. - mitapivat sulfate - genetic diseases, inborn; anemia, hemolytic - other hematological agents - pyrukynd is indicated for the treatment of pyruvate kinase deficiency (pk deficiency) in adult patients (see section 4.

איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

atnahs pharma netherlands b.v. - olsalazinum natríum - tafla - 500 mg

איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

atnahs pharma netherlands b.v. - olsalazinum natríum - hart hylki - 250 mg

איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

prothya biosolutions netherlands b.v. - human serum albumin - innrennslislyf, lausn - 200 g/l

איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

prothya biosolutions netherlands b.v. - human albumin - innrennslislyf, lausn - 40 g/l

איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

prothya biosolutions netherlands b.v. - factor ii human; factor vii human; factor ix human; factor x human - stungulyfsstofn og leysir, lausn - 500 a.e.

האיחוד האירופי - איסלנדית - EMA (European Medicines Agency)

taiho pharma netherlands b.v. - futibatinib - cholangiocarcinoma - antineoplastic lyfjum - lytgobi monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.